Prongay & Murray LLP ("GPM"), a global investors rights law
firm, announces that a class action lawsuit has been filed on behalf of
investors that purchased or otherwise acquired Liberty Health Sciences
Inc. ("Liberty" or the "Company") (OTC: LHSIF)
securities between June 28, 2018 and December 3, 2018, inclusive
(the "Class Period"). Liberty investors have until March 8, 2019 to
file a lead plaintiff motion.
If you are a shareholder who suffered a loss, click here to
In September 2018, Liberty sold its stake in Aphria Inc. ("Aphria"). On
December 3, 2018, Quintessential Capital Manaement and Hindenburg
Research issued a report entitled "Aphria: A Shell Game with a Cannabis
Business on the Side," claiming that Aphria was part of a scheme
orchestrated by a network of insiders to divert funds away from
shareholders and into their own pockets.
On this news, Liberty's stock price fell $0.36 per share, or nearly 34%,
over the next two trading days to close at $0.70 on December 4, 2018,
thereby injuring investors.
The complaint filed in this class action alleges that defendants made
false and/or misleading statements and/or failed to disclose that: (i)
Liberty, in conjunction with Aphria, was involved in a scheme whereby
numerous fraudulent acquisitions and transactions were made to provide
undue benefits to both companies' insiders; and (ii) as a result,
Liberty's public statements were materially false and misleading at all
Follow us for updates on Twitter (News - Alert): twitter.com/GPM_LLP.
If you purchased shares of Liberty during the Class Period you may move
the Court no later than March 8, 2019 to ask the Court
to appoint you as lead plaintiff. To be a member of the Class you need
not take any action at this time; you may retain counsel of your choice
or take no action and remain an absent member of the Class. If you wish
to learn more about this action, or if you have any questions concerning
this announcement or your rights or interests with respect to these
matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century
Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150,
Toll-Free at 888-773-9224, by email to firstname.lastname@example.org,
or visit our website at www.glancylaw.com.
If you inquire by email please include your mailing address, telephone
number and number of shares purchased.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190110005021/en/
[ Back To Homepage ]